Skip to Content

93 5150 (Moexipril 15 mg)

Pill imprint 93 5150 has been identified as Moexipril hydrochloride 15 mg.

Moexipril is used in the treatment of diabetic kidney disease; high blood pressure; heart attack; left ventricular dysfunction; heart failure and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Moexipril 15 mg is not a controlled substance under the Controlled Substance Act (CSA).

Moexipril hydrochloride 15 mg 93 5150
Moexipril hydrochloride 15 mg 93 5150 Front
Moexipril hydrochloride 15 mg 93 5150 Back
Moexipril hydrochloride 15 mg 93 5150
Moexipril hydrochloride
Imprint:
93 5150
Strength:
15 mg
Color:
Pink
Size:
10.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Angiotensin converting enzyme inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-5150
Inactive Ingredients:
crospovidone
lactose monohydrate
magnesium stearate
corn starch
sodium bicarbonate
hypromellose 2910 (15 mPa.s)
ferric oxide red
titanium dioxide
triacetin

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide